Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes
See More

In The News

Roche’s Lunsumio eyes year-end FDA verdict to be first bispecific for non-Hodgkin lymphoma aliu Wed, 07/06/2022 – 09:39

https://www.fiercepharma.com/pharma/roche-eyes-year-end-lunsumio-fda-verdict-be-first-bispecific-non-hodgkin-lymphoma

Viatris starts yet another insulin biosimilar recall over potential missing labels fkansteiner Wed, 07/06/2022 – 09:12

https://www.fiercepharma.com/manufacturing/viatris-charts-insulin-biosimilar-recall-over-potential-missing-label-again

GSK’s consumer health spinoff Haleon will launch with ‘significant’ debt under its belt: report zbecker Tue, 07/05/2022 – 10:08

https://www.fiercepharma.com/pharma/gsks-consumer-health-spinoff-haleon-will-launch-103-billion-pounds-debt-under-its-belt

How Pfizer CEO Bourla’s evening call brought Biohaven back into the M&A fold aliu Tue, 07/05/2022 – 10:33

https://www.fiercepharma.com/pharma/how-pfizer-ceo-bourlas-evening-call-brought-biohaven-back-ma-bandwagon

Roche, Pfizer and ViiV top patient groups’ views of leading pharmas for ESG work: Report badams Tue, 07/05/2022 – 09:22

https://www.fiercepharma.com/marketing/viiv-roche-and-pfizer-top-patient-groups-views-leading-pharmas-esg-work-report

Seagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M opportunity zbecker Tue, 07/05/2022 – 11:16

https://www.fiercepharma.com/pharma/seagen-touts-new-tukysa-data-colorectal-cancer-median-progression-free-survival-rate-87

Test 2
Virtual September 05-20

Test
Virtual August 03-16

Testing
Virtual July 08-20

Lorem ipsum
Virtual June 11-22

American Society of Hematology Annual Meeting and Exposition (ASH)
Atlanta/Virtual Hybrid December 11-14

Society for Neuro-Oncology Annual Meeting (SNO)
Boston, MA November 18-21

See More Events

Read More Articles